Skip to main content
. Author manuscript; available in PMC: 2018 Sep 22.
Published in final edited form as: Sci Transl Med. 2014 Apr 16;6(232):232ra51. doi: 10.1126/scitranslmed.3008068

Fig. 2. Induction of anti–NY-ESO-1 IgG titers in patients vaccinated with CDX-1401.

Fig. 2.

Pre- and posttreatment sera were tested for anti–NYESO-1 IgG responses by enzyme-linked immunosorbent assay (ELISA) using full-length recombinant NY-ESO-1. The titer was established by determining the endpoint dilution with the peak response shown by color map as indicated in the legend. Patients with archival tumor that demonstrated NY-ESO-1 expression by IHC or PCR are indicated with green shading. Patients who experienced stable disease are indicated by asterisk.